sunlenca
gilead sciences ireland unlimited company - lenacapavir sodium - Živ infekcijos - antivirusiniai vaistai sisteminiam naudojimui - sunlenca injection, in combination with other antiretroviral(s), is indicated for the treatment of adults with multidrug resistant hiv 1 infection for whom it is otherwise not possible to construct a suppressive anti viral regimen (see sections 4. 2 ir 5. sunlenca tablet, in combination with other antiretroviral(s), is indicated for the treatment of adults with multidrug resistant hiv 1 infection for whom it is otherwise not possible to construct a suppressive anti viral regimen, for oral loading prior to administration of long-acting lenacapavir injection (see sections 4. 2 ir 5.
vocabria
viiv healthcare b.v. - cabotegavir sodium, cabotegravir - Živ infekcijos - antivirusiniai vaistai sisteminiam naudojimui - vocabria tablets are indicated in combination with rilpivirine tablets for the short-term treatment of human immunodeficiency virus type 1 (hiv-1) infection in adults who are virologically suppressed (hiv-1 rna.
macox zh jr
nenurodyta - rifampicinas/izoniazidas/pirazinamidas - plėvele dengtos tabletės - 120 mg/50 mg/300 mg - rifampicin, pyrazinamide and isoniazid
rifoldin
actiofarma, uab - rifampicinas - milteliai ir tirpiklis infuziniam tirpalui - 600 mg - rifampicin
volibris
glaxosmithkline (ireland) limited - ambrisentanas - hipertenzija, plaučių vėžys - antihipertenzinių vaistų, - volibris is indicated for treatment of pulmonary arterial hypertension (pah) in adult patients of who functional class (fc) ii to iii, including use in combination treatment (see section 5. efficacy has been shown in idiopathic pah (ipah) and in pah associated with connective tissue disease. volibris is indicated for treatment of pah in adolescents and children (aged 8 to less than 18 years) of who functional class (fc) ii to iii including use in combination treatment. efficacy has been shown in ipah, familial, corrected congenital and in pah associated with connective tissue disease (see section 5.
dexamethasone sodium phosphate
niromed, uab - deksametazono natrio fosfatas - injekcinis ar infuzinis tirpalas - 4 mg/ml - dexamethasone
natrio jodidas [¹³¹ i] ge healthcare
ge healthcare buchler gmbh & co. kg - natrio jodidas [¹³¹ i] - injekcinis tirpalas - 0,329-3,7 mbq; 0,333-3,7 mbq; 74 mbq/ml; 925 mbq/ml - sodium iodide (131i);sodium iodide (131i)
rekambys
janssen-cilag international nv - rilpivirine - Živ infekcijos - antivirusiniai vaistai sisteminiam naudojimui - rekambys is indicated, in combination with cabotegravir injection, for the treatment of human immunodeficiency virus type 1 (hiv 1) infection in adults who are virologically suppressed (hiv-1 rna < 50 copies/ml) on a stable antiretroviral regimen without present or past evidence of viral resistance to, and no prior virological failure with, agents of the nnrti and ini class.
pantoprazole kalceks
as kalceks - pantoprazolas - milteliai injekciniam tirpalui - 40 mg - pantoprazole
dexamethasone kalceks
as kalceks - deksametazono natrio fosfatas - injekcinis ar infuzinis tirpalas - 4 mg/ml - dexamethasone